Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in US…
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
Facility expected to be operational in 2028 in Dallas-Fort Worth area, expanding largest RLT manufacturing network in US…
Novartis to build radioligand therapy site in Texas to expand US manufacturing
Feb 25 (Reuters) – Novartis said on Wednesday it intends to build a radioligand therapy manufacturing site in…
Novartis to build new radioligand therapy site in Texas to deliver next-generation treatments
Today Novartis announced plans to establish a new 46,000-square-foot radioligand therapy (RLT) manufacturing site in Denton, Texas. This purpose-built RLT site will…